EmTech (EmergingTech Ventures)

Profile

EmTech is a venture capital firm based in Morocco that was established to support founder-led ventures in emerging markets. The firm is entrepreneur-driven, focusing on bold and transformative founders. With a small team of investors who have a deep understanding of their respective markets, EmTech helps these founders scale their operations and become regional leaders. What sets EmTech apart is its hands-on approach and commitment to sustainable growth in Francophone Africa and beyond.

EmTech invests primarily in early-stage startups, with a focus on Seed and Pre-A stages. The firm's investment sectors include AI, HealthTech, Fintech, SaaS, and AgriTech. Their geographic focus spans Morocco, Tunisia, and Francophone Africa. Notably, EmTech has established the Early-Stage Fund with $60 million dedicated to supporting startups at the early stages of development, deploying checks typically ranging from $500K to $3 million.

The venture has a notable portfolio, with companies like Spore.bio - AI-driven synthetic biology, Docline - digital healthcare consultations, Unissey - facial biometric authentication, and SOWIT - precision agriculture. These investments underline EmTech's commitment to fostering innovation in the tech sectors within Africa, providing the necessary capital and support to unlock their potential.